OncoMatch/Clinical Trials/NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
Is NCT07761351 recruiting? Yes, currently enrolling (Sep 2026). This Phase 4 trial studies non-drug interventions for lung cancer (diagnosis).
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Prior therapy
Cannot have received: biopsy of target nodule
Patient has previously undergone a biopsy procedure of the target nodule by any approach
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07761351 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior biopsy of target nodule disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify